{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:12:47Z","timestamp":1788883967279,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["24xkjc021"],"award-info":[{"award-number":["24xkjc021"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["251000310100"],"award-info":[{"award-number":["251000310100"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300421126"],"award-info":[{"award-number":["252300421126"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515120085"],"award-info":[{"award-number":["2022B1515120085"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272785"],"award-info":[{"award-number":["82272785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20241202130045054"],"award-info":[{"award-number":["JCYJ20241202130045054"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2026.114645","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:21:01Z","timestamp":1769127661000},"page":"114645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of a lymph node-homing peptide vaccine targeting C-C chemokine receptor 7-positive dendritic cells with enhanced antitumor immunity"],"prefix":"10.1016","volume":"391","author":[{"given":"Liwei","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114645_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114645_bb0010","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1158\/1078-0432.CCR-18-0638","article-title":"Antigen-specific CD8 lytic phenotype induced by Sipuleucel-T in hormone-sensitive or castration-resistant prostate Cancer and association with overall survival","volume":"24","author":"Antonarakis","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114645_bb0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(18)30254-7","article-title":"MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Dreno","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0020","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2026.114645_bb0025","doi-asserted-by":"crossref","first-page":"30701","DOI":"10.1021\/acsnano.4c09902","article-title":"Spleen-targeted mRNA vaccine doped with manganese adjuvant for robust anticancer immunity in vivo","volume":"18","author":"Luo","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114645_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-0795-4_1","article-title":"Vaccine delivery and immune response basics","volume":"2183","author":"Hill","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0035","article-title":"Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum","volume":"5","author":"Ingels","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2026.114645_bb0040","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1002\/ijc.34453","article-title":"A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma","volume":"152","author":"Ishihara","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114645_bb0045","article-title":"Remodeling the tumor immune microenvironment through hydrogel encapsulated G-Rh2 in situ vaccine and systemic immunotherapy","volume":"29","author":"Li","year":"2024","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.jconrel.2026.114645_bb0050","article-title":"Targeting antigen-presenting cells to enhance the tumor-spleen immunity cycle through liposome-neoantigen vaccine","volume":"12","author":"Xu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.114645_bb0055","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.7150\/thno.110305","article-title":"Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes","volume":"15","author":"Wei","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114645_bb0060","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/acs.nanolett.4c06123","article-title":"Development of a Cascade-targeting Oral vaccine via glycoprotein 2 on intestinal microfold cells for Cancer immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114645_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.02.007","article-title":"beta-glucan-modified nanoparticles with different particle sizes exhibit different lymphatic targeting efficiencies and adjuvant effects","volume":"14","author":"Guo","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.114645_bb0070","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1039\/D5BM00317B","article-title":"Cyclen-based lipidoids for mRNA delivery and immunotherapy","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114645_bb0075","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1039\/D4CS00421C","article-title":"Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond","volume":"53","author":"Hsu","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.114645_bb0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12951-023-01977-1","article-title":"Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12967-017-1283-8","article-title":"Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies","volume":"15","author":"Shukla","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114645_bb0090","article-title":"Dendritic cell-hitchhiking in vivo for vaccine delivery to lymph nodes","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.114645_bb0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12951-023-01989-x","article-title":"Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0100","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jconrel.2025.01.087","article-title":"An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy","volume":"379","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114645_bb0105","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.21873\/anticanres.17196","article-title":"Personalized dendritic-cell-based vaccines targeting Cancer neoantigens","volume":"44","author":"Kamigaki","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2026.114645_bb0110","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3389\/fimmu.2018.01923","article-title":"Enhancement of antitumor vaccination by targeting dendritic cell-related IL-10","volume":"9","author":"Llopiz","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.950597","article-title":"Human dendritic cell targeting peptide can be targeted to porcine dendritic cells to improve antigen capture efficiency to stimulate stronger immune response","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114645_bb0125","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1021\/acs.nanolett.1c03243","article-title":"Engineered Nanovaccine targeting Clec9a+ dendritic cells remarkably enhances the Cancer immunotherapy effects of STING agonist","volume":"21","author":"Gou","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114645_bb0130","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.7150\/thno.56406","article-title":"Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk\/IL-21 axis","volume":"11","author":"Gou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114645_bb0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jconrel.2024.07.056","article-title":"Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy","volume":"373","author":"Zheng","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114645_bb0140","first-page":"9","article-title":"Cross-presenting XCR1(+) dendritic cells as targets for Cancer immunotherapy","author":"Audsley","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114645_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00262-025-04070-8","article-title":"Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer","volume":"74","author":"Fan","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.114645_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/gtmb.2017.0125","article-title":"Expression of the chemokine receptor CXCR3 correlates with dendritic cell recruitment and prognosis in gastric Cancer","volume":"22","author":"Chen","year":"2017","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.jconrel.2026.114645_bb0155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0160","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-024-44787-1","article-title":"Tumour-retained activated CCR7(+) dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114645_bb0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"issue":"4734\u201352","key":"10.1016\/j.jconrel.2026.114645_bb0170","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114645_bb0175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114645_bb0180","article-title":"CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.114645_bb0185","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.20102392","article-title":"DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling","volume":"208","author":"Tal","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.114645_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13025","article-title":"Peptide-based therapeutic cancer vaccine: current trends in clinical application","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jconrel.2026.114645_bb0195","first-page":"9","article-title":"Peptide-Based Therapeutics for Oncology","volume":"33","author":"Fisher","year":"2019","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/j.jconrel.2026.114645_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-025-03995-4","article-title":"A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis","volume":"74","author":"Sun","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.114645_bb0205","first-page":"15","article-title":"CCR7 mediates dendritic-cell-derived exosome migration and improves cardiac function after myocardial infarction","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114645_bb0210","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1038\/s41598-024-57941-y","article-title":"The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer","volume":"14","author":"Trimaglio","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.114645_bb0215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4049\/jimmunol.1801108","article-title":"The cross-talk between miR-511-3p and C-type lectin receptors on dendritic cells affects dendritic cell function","volume":"203","author":"Awuah","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1189\/jlb.5MR0217-059RR","article-title":"Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines","volume":"102","author":"van Dinther","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2026.114645_bb0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ar.21015","article-title":"SLC\/CCR7 stimulates the proliferation of BMDCs by the pNF-kappaB p65 pathway","volume":"293","author":"Zhou","year":"2010","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.jconrel.2026.114645_bb0230","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1038\/s41467-025-60769-3","article-title":"Orchestrating intratumoral DC-T cell immunity for enhanced tumor control via radiotherapy-activated TLR7\/8 prodrugs in mice","volume":"16","author":"Yin","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:38:09Z","timestamp":1781771889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"alternative-id":["S0168365926000465"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114645","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a lymph node-homing peptide vaccine targeting C-C chemokine receptor 7-positive dendritic cells with enhanced antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114645"}}